JP7765027B1 - アルツハイマー病予防若しくは治療用組成物 - Google Patents
アルツハイマー病予防若しくは治療用組成物Info
- Publication number
- JP7765027B1 JP7765027B1 JP2025544453A JP2025544453A JP7765027B1 JP 7765027 B1 JP7765027 B1 JP 7765027B1 JP 2025544453 A JP2025544453 A JP 2025544453A JP 2025544453 A JP2025544453 A JP 2025544453A JP 7765027 B1 JP7765027 B1 JP 7765027B1
- Authority
- JP
- Japan
- Prior art keywords
- composition
- pls
- present disclosure
- group
- bace1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024003975 | 2024-01-15 | ||
| JP2024003975 | 2024-01-15 | ||
| PCT/JP2025/000770 WO2025154692A1 (ja) | 2024-01-15 | 2025-01-14 | アルツハイマー病予防若しくは治療用組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2025154692A1 JPWO2025154692A1 (https=) | 2025-07-24 |
| JP7765027B1 true JP7765027B1 (ja) | 2025-11-06 |
| JPWO2025154692A5 JPWO2025154692A5 (https=) | 2025-12-16 |
Family
ID=96471267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025544453A Active JP7765027B1 (ja) | 2024-01-15 | 2025-01-14 | アルツハイマー病予防若しくは治療用組成物 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP7765027B1 (https=) |
| TW (1) | TW202539627A (https=) |
| WO (1) | WO2025154692A1 (https=) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012039472A1 (ja) * | 2010-09-24 | 2012-03-29 | 医療法人社団ブックス | 抗中枢神経系炎症剤 |
-
2025
- 2025-01-13 TW TW114101315A patent/TW202539627A/zh unknown
- 2025-01-14 JP JP2025544453A patent/JP7765027B1/ja active Active
- 2025-01-14 WO PCT/JP2025/000770 patent/WO2025154692A1/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012039472A1 (ja) * | 2010-09-24 | 2012-03-29 | 医療法人社団ブックス | 抗中枢神経系炎症剤 |
Non-Patent Citations (12)
| Title |
|---|
| "プラズマローゲン「記憶」「認知機能」をサポートする鶏ムネ肉由来の機能性素材「Plasmax」", [オンライン], JPN6025011366, 2023, ISSN: 0005704504 * |
| BIOLOGICAL ＆ PHARMACEUTICAL BULLETIN, vol. 47, no. 1, JPN6025040710, 26 January 2024 (2024-01-26), pages 192 - 195, ISSN: 0005704499 * |
| Biological ＆ Pharmaceutical Bulletin，2024年01月26日，Vol. 47，No. 1，p.192－195 |
| IFUKU, M. et al.，Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinfl，Journal of Neuroinflammation，2012年，9:197，1-13 |
| IFUKU, M. ET AL.: "Anti-inflammatory/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinfl", JOURNAL OF NEUROINFLAMMATION, vol. 9:197, JPN6025011363, 2012, pages 1 - 13, ISSN: 0005704503 * |
| ROTHHAAR, Tatjana L. et al.，Plasmalogens Inhibit APP Processing by Directly Affecting γ-Secretase Activity in Alzheimer’s Dise，The Scientific World Journal，2012年，141240 |
| ROTHHAAR, TATJANA L. ET AL.: "Plasmalogens Inhibit APP Processing by Directly Affecting γ-Secretase Activity in Alzheimer’s Dise", THE SCIENTIFIC WORLD JOURNAL, vol. 141240, JPN6025011362, 2012, ISSN: 0005704500 * |
| YAMAGIWA, Natsuki et al.，Phosphatidylcholine-Plasmalogen-Oleic Acid Has Protective Effects against Arachidonic Acid-Induced C，Biological and Pharmaceutical Bulletin，2022年，Volume 45, Issue 5，Pages 643-648 |
| YAMAGIWA, NATSUKI ET AL.: "Phosphatidylcholine-Plasmalogen-Oleic Acid Has Protective Effects against Arachidonic Acid-Induced C", BIOLOGICAL AND PHARMACEUTICAL BULLETIN, vol. Volume 45, Issue 5, JPN6025011364, 2022, pages 643 - 648, ISSN: 0005704502 * |
| プラズマローゲン「記憶」「認知機能」をサポートする鶏ムネ肉由来の機能性素材「Plasmax」，[オンライン]，健康美容EXPO，2023年，インターネット:<URL: https://e-expo.net/information/plasmalogen/> |
| 岡林春花、安田美紀、新居千夏、福島圭穣、湯浅浩気、琴浦聡、藤野裕道，プラズマローゲンによるアルツハイマー病発症予防メカニズムの解明，The 143rd Annual Meeting of the Pharmaceutical Society of Japan (Sapporo)，2023年，26P2-pm1-007S |
| 岡林春花、安田美紀、新居千夏、福島圭穣、湯浅浩気、琴浦聡、藤野裕道: "プラズマローゲンによるアルツハイマー病発症予防メカニズムの解明", THE 143RD ANNUAL MEETING OF THE PHARMACEUTICAL SOCIETY OF JAPAN (SAPPORO), vol. 26P2-pm1-007S, JPN6025011365, 2023, ISSN: 0005704501 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202539627A (zh) | 2025-10-16 |
| JPWO2025154692A1 (https=) | 2025-07-24 |
| WO2025154692A1 (ja) | 2025-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101997060B1 (ko) | 발효 녹용을 유효성분으로 포함하는 근육 질환 예방 또는 치료용, 또는 근 기능 개선용 조성물 | |
| JP6201054B2 (ja) | モノアセチルジアシルグリセロール化合物を有効成分として含有する血液癌または癌転移抑制用組成物 | |
| JP2019520319A (ja) | 小豆を含む筋機能改善又は運動遂行能力向上用組成物 | |
| KR100399671B1 (ko) | 고혈압증또는이에기인하는의학적증상의예방또는개선제 | |
| JP2015096494A (ja) | 生体内酸化還元状態改善剤 | |
| EP0488513A2 (en) | Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol. | |
| CA2525486C (en) | Composition for lowering the internal lipid | |
| US6310100B1 (en) | Method of treating hypertension | |
| JP7765027B1 (ja) | アルツハイマー病予防若しくは治療用組成物 | |
| KR101584431B1 (ko) | 달맞이꽃 추출물을 유효성분으로 함유하는 미소중력하 또는 신경손상으로 인한 근위축 예방 또는 치료용 약학 조성물 | |
| KR101903905B1 (ko) | 핑클루비 (Sedeveria Pink Ruby) 추출물을 유효성분으로 포함하는, 항암 또는 항산화용 조성물 | |
| KR20160131957A (ko) | 미생물 공서 배양를 통한 천연 발효 추출물을 함유하는 치주질환 예방 또는 개선용 조성물 | |
| KR20070108291A (ko) | 알레르기 증상의 예방 또는 개선 작용을 갖는 음식물 및당해 음식물의 제조방법 | |
| WO2015152684A1 (ko) | 오미자 추출물의 에틸아세테이트 분획물을 유효성분으로 포함하는 염증 질환의 예방 및 치료용 약학적 조성물 또는 상처치유용 약학적 조성물 | |
| US20180296520A1 (en) | Method for treating paroxysmal nocturnal hemoglobinuria | |
| JP2005206520A (ja) | アテローム性動脈硬化抑制剤ならびにこれを含む食品および医薬 | |
| JP6103796B2 (ja) | コラーゲンゲル収縮促進剤の選択方法 | |
| JP6456032B2 (ja) | Ｓｉｒｔ１活性化剤および当該Ｓｉｒｔ１活性化剤の利用 | |
| JP2018058792A (ja) | Ｐｃｓｋ９阻害剤及びコレステロール代謝改善用食品組成物 | |
| KR102063321B1 (ko) | 와송 추출물을 포함하는 자궁근종 예방 또는 치료용 약학 조성물 | |
| JP6398014B2 (ja) | ラマリンを含有する退行性脳疾患の予防または治療用組成物 | |
| KR20140093573A (ko) | 디하이드로진저론을 함유하는 비만 치료 또는 예방용 조성물 | |
| EP4167978B1 (en) | Use of juniper (juniperus communis) berries extract, deoxypodophyllotoxin and agathadiol, as positive allosteric modulators of cannabinoid type 1 receptor for treating neuropathic pain and inflammatory pain | |
| JP2009114138A (ja) | コレステロール上昇抑制剤 | |
| KR102279883B1 (ko) | 미크란디락톤 c를 포함하는 염증성 질환의 예방 또는 치료용 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250730 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250730 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A801 Effective date: 20250730 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20250730 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20250730 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20251007 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20251015 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7765027 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |